Proliferating Cell Nuclear Antigen Expression in Renal Cell Carcinoma: Prognostic Implications

Scandinavian Journal of Urology and Nephrology

Volumn 30, Issue 6, 1996, Pages 445-450

  Larsson, Per ^a,b   Roos, Göran ^a   Stenling, Roger ^a   Ljungberg, Börje ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

DNA ploidy; PCNA; Prognosis; Proliferation; Renal cell carcinoma; Stage

Indexed keywords

CYCLINE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CELL DIVISION; CELL NUCLEUS; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PLOIDIES; PROLIFERATING CELL NUCLEAR ANTIGEN; SURVIVAL RATE;

EID: 0030443442     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365599609182321     Document Type: Article

References (21)

1. Cronin KJ, Williams NN, Kerin MJ, et al. Proliferating cell nuclear antigen: a new prognostic indicator in renal cell carcinoma. J Urol 1994; 152: 834-836.
2. Figge C, Reifenberger G, Vogeley KT, Messing M, Roosen N, Wechsler W. Immunohistochemical demonstration of proliferating cell nuclear antigen in glioblastomas: pronounced heterogeneity and lack of prognostic significance. J Cancer Res Clin Oncol 1992; 118: 289-295.
3. Grignon DJ, Ayala AG, El-Naggar A, et al. Renal cell carcinoma. A clinico-pathologic and DNA flow cytometric analysis of 103 cases. Cancer 1989; 64: 2133-2140.
4. Hall PA, Levinson DA, Wood AL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalisation in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J. Pathol 1990; 162: 285-289.
5. Harper ME, Glynne-Jones L, Goddard L, et al. Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters. Prostate 1992; 20: 243-253.
6. Jain S, Filipe MI, Hall PA, Waseem N, Lane DP, Levison DA. Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol 1991; 44: 655-659.
7. Larsson P, Roos G, Stenling R, Ljungberg B. Tumor cell proliferation and prognosis in renal cell carcinoma. Int J Cancer 1993; 55: 566-570.
8. Linden WA, K - Ilermann M, König K. Flowcytometric and autoradiographic studies of human kidney carcinomas surgically removed after preirradiation. Br J Cancer 1980; 41: 177-180.
9. Ljungberg B, Larsson P, Roos G, Stenling R, Wilson G. Cell kinetics of renal cell carcinoma studied with in vivo iododeoxyuridine incorporation and flow cytometry. J Urol 1994; 151: 1509-1513.
10. Ljungberg B, Stenling R, Roos G. DNA content in renal cell carcinoma with reference to tumor heterogeneity. Cancer 1985; 56: 503-508.
11. Ljungberg B., Stenling R., Roos G. Prognostic value of the deoxyribonucleic acid content in metastatic renal cell carcinoma. J Urol 1986; 136: 801-804.
12. Malmström PU, Wester K, Vasko J, Busch C. Expression of PCNA in urinary bladder carcinoma. Evaluation of antigen retrieval methods. APMIS 1992; 100: 151-158.
13. Mathews MB, Bernstein RM, Franza BR, Garrels JI. Identity of the proliferating cell nuclear antigen and cyclin. Nature 1984; 303: 374-376.
14. Morris GF, Mathews MB Regulation of proliferating cell nuclear antigen during the cell cycle, J Cell Biol 1989; 264: 13856-13858.
15. Oka K, Hoshi T, Arai T. Prognostic significance of the PC10 index as a prospective assay for cervical cancer treated with radiation therapy alone. Cancer 1992; 70: 1545-1549.
16. Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 1969; 101: 297-301.
17. Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF. Diagnosis and management of renal cell carcinoma. A clinical and pathological study of 309 cases. Cancer 1971; 28: 1165-1177.
18. Skopelitou A, Korkolopoulou P, Papanicolaou A, Christodoulou P, Thomas-Tsagli E, Pavlakis K. Comparative assessment of proliferating cell nuclear antigen immunostaining and of nucleolar organizer region staining in transitional cell carcinomas of the urinary bladder. Eur Urol 1992; 22: 235-240.
19. Tribukait B. Flow cytometry in assessing the clinical aggressiveness of genitourinary neoplasms. World J Urol 1987; 5: 108-122.
20. Villari D, Nicita G, Ponchietti R, et al. Tumor proliferative fraction in renal cell carcinoma. A comparative study of PCNA immunostaining and flow cytometry. Proceeding, European Association of Urology, XIth congress, 1994; p. 252.
21. Waseem NH, Lane DP. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conversion and the detection of a nucleolar form. J Cell Sci 1990; 90: 121-125.